Literature DB >> 2947566

Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.

B Maisch.   

Abstract

In acute perimyocarditis we found that OKIAI-positive cells were increased, and in dilated cardiomyopathy OKMI-positive cells were increased. No significant alteration in suppressor T cell activity was observed in our patients with either disease. The characteristic immunofluorescent pattern in carditis and postmyocarditic heart disease is the presence of antimyolemmal antibodies with intact rat and human cardiocytes in titers of 1:40-1:320 as antigens. The antimyolemmal fluorescence can be absorbed with the respective causative virus in Coxsackie B, influenza, mumps and EBV-myocarditis, indicating that the antibodies are a cross-reactive. AMLA-positive sera induce cytolysis of vital rat cardiocytes in vitro, suggesting that the antibodies are of pathogenetic relevance. Cytolytic serum activity could be absorbed out with the respective virus. Immunohistologic specimens obtained from patients with carditis demonstrate the fixation of IgG and IgM antibodies; IgG antibodies also occur in dilated cardiomyopathy and coronary artery disease. In dilated postmyocarditic heart disease both antimyolemmal fluorescence and cytolytic activity are preserved at a lower level when compared to carditis. These antibodies can also fix complement. In the acute phase of carditis circulating immune complexes can be demonstrated. Cellular effector mechanisms against vital cardiocytes were maintained or even slightly enhanced in carditis, postmyocarditic and primary dilated cardiomyopathy. In vitro NK cell activity against K 562, however, was decreased. This is compatible with a sustained target-specific cytotoxicity whereas reduced NK cell activity may indicate impairment of this effector organ.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947566     DOI: 10.1007/978-3-662-11374-5_21

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  13 in total

1.  Immunological features in a case of hypereosinophilic syndrome and myocarditis.

Authors:  B Maisch; L Drude; K Kochsiek
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

Review 2.  Anti-viral and anti-myocyte antibodies in experimental myocarditis.

Authors:  M Herzum; B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

Review 3.  [Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].

Authors:  S Pankuweit; G Hufnagel; H Eckhardt; H Herrmann; S Uttecht; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 4.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

5.  [Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?].

Authors:  B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 6.  Humoral immune response to cardiac conducting tissue.

Authors:  U Lotze; B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

Review 7.  Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury.

Authors:  B Maisch
Journal:  Springer Semin Immunopathol       Date:  1989

8.  Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.

Authors:  T Yokoyama; T Kanda; T Suzuki; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

9.  Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci.

Authors:  S A Huber; A Moraska; M Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  [Perimyocarditis in influenza A virus infection].

Authors:  D Franzen; T Mertens; T Waidner; J Kruppenbächer; H W Höpp; H H Hilger
Journal:  Klin Wochenschr       Date:  1991-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.